StrAtegies For Zoledronic Acid Post-dEnosumab Discontinuation in Postmenopausal oSTeoporosis — StellaPhase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(17 sites)
France
Bordeaux Hospital, Bordeaux Le Mans Hospital, Le Mans Limoges Hospital, Limoges Marseille Hsopital, Marseille Montpellier Hospital, Montpellier Orléans Hospital, Orléans Lariboisiere Hospital, Paris Poitiers Hospital, Poitiers Saint Etienne Hospital, Saint-Etienne Toulouse Hospital, Toulouse Last updated December 2025